These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds. Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830 [TBL] [Abstract][Full Text] [Related]
4. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932 [TBL] [Abstract][Full Text] [Related]
5. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532 [TBL] [Abstract][Full Text] [Related]
6. Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent. Dalos D; Gangl C; Roth C; Krenn L; Scherzer S; Vertesich M; Lang I; Maurer G; Neunteufl T; Berger R; Delle-Karth G BMC Cardiovasc Disord; 2016 May; 16():104. PubMed ID: 27225486 [TBL] [Abstract][Full Text] [Related]
7. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions. Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010 [TBL] [Abstract][Full Text] [Related]
8. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials? Rizik DG; Hermiller JB; Simonton CA; Klassen KJ; Kereiakes DJ Coron Artery Dis; 2017 Jan; 28(1):77-89. PubMed ID: 27561169 [TBL] [Abstract][Full Text] [Related]
9. A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions. Jabbour RJ; Ielasi A; Tanaka A; Leoncini M; Cortese B; Grigis G; Mitomo S; Regazzoli D; Di Palma G; Rapetto C; Tespili M; Colombo A; Latib A Cardiovasc Revasc Med; 2017; 18(5S1):S4-S9. PubMed ID: 28314675 [TBL] [Abstract][Full Text] [Related]
10. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622 [TBL] [Abstract][Full Text] [Related]
11. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure. Tanaka A; Jabbour RJ; Latib A; Colombo A Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460 [TBL] [Abstract][Full Text] [Related]
12. Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology. Chamié D; Garcia-Garcia H; Costa RA; Onuma Y; Abizaid A; Serruys PW Catheter Cardiovasc Interv; 2016 Nov; 88(S1):38-53. PubMed ID: 27797463 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year follow-up: A systematic review and meta-analysis of studies. Mukete BN; van der Heijden LC; Tandjung K; Baydoun H; Yadav K; Saleh QA; Doggen CJ; Abi Rafeh N; Le Jemtel TH; von Birgelen C Int J Cardiol; 2016 Oct; 221():1087-94. PubMed ID: 27448538 [TBL] [Abstract][Full Text] [Related]
14. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting. Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306 [No Abstract] [Full Text] [Related]
15. [Bioresorbable Vascular Scaffold: A Focused Review on Development and Preclinical Studies]. Ke L; Huang Y; Liu L; Duan X; Feng X; Wang C Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Feb; 42(2):115-118. PubMed ID: 29845812 [TBL] [Abstract][Full Text] [Related]
16. Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trial. Kallinikou Z; Arroyo D; Togni M; Lehman S; Corpataux N; Cook M; Müller O; Baeriswyl G; Stauffer JC; Goy JJ; Puricel SG; Cook S Swiss Med Wkly; 2016; 146():w14274. PubMed ID: 26766027 [TBL] [Abstract][Full Text] [Related]
17. Intracoronary Imaging for Assessment of Vascular Healing and Stent Follow-up in Bioresorbable Vascular Scaffolds. Florin Ferent I; Mester A; Hlinomaz O; Groch L; Rezek M; Sitar J; Semenka J; Novak M; Benedek I Curr Med Imaging Rev; 2020; 16(2):123-134. PubMed ID: 32003312 [TBL] [Abstract][Full Text] [Related]